Fig. 1From: Increased circulating resistin levels in early-onset breast cancer patients of normal body mass index correlate with lymph node negative involvement and longer disease free survival: a multi-center POSH cohort serum proteomics studyExperimental design for the high-precision LC-MS proteomic discovery analysis, data reduction and subsequent targeted validation pipeline. BrCA breast cancer, ELISA enzyme-linked immunosorbent assay, BMI body mass index, LN lymph node, ER oestrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2Back to article page